# First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer

> **NCT05460780** · NA · RECRUITING · sponsor: **Quanta Medical** · enrollment: 50 (estimated)

## Conditions studied

- Breast Cancer Female
- Breast Cancer Prevent
- Breast Reconstruction

## Interventions

- **DEVICE:** MATTISSE TEC

## Key facts

- **NCT ID:** NCT05460780
- **Lead sponsor:** Quanta Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05460780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05460780, "First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05460780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*